My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 309

    1.

    Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.

    van den Berk G, Tonino S, de Fijter C, Smit W, Schultz MJ.

    Crit Care. 2005 Aug;9(4):361-70. Epub 2005 Jan 7. Review.PMID: 16137385 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    N-acetylcysteine and other preventive measures for contrast-induced nephropathy in the intensive care unit.

    Schultz MJ, Baas MC, van der Sluijs HP, Stamkot GA, Smit W.

    Curr Med Chem. 2006;13(21):2565-70. Review.PMID: 17017911 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Contrast induced nephropathy]

    Hörl WH.

    Wien Klin Wochenschr. 2009;121(1-2):15-32. Review. German. PMID: 19263010 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Iodinated contrast agent-induced nephropathy]

    Erley C.

    Radiologe. 2007 Sep;47(9):761-7. Review. German. PMID: 17823784 [PubMed - indexed for MEDLINE]Related articles

    5.

    Facts and fallacies concerning the prevention of contrast medium-induced nephropathy.

    Meschi M, Detrenis S, Musini S, Strada E, Savazzi G.

    Crit Care Med. 2006 Aug;34(8):2060-8. Review.PMID: 16763513 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical significance and preventive strategies for contrast-induced nephropathy.

    Sterling KA, Tehrani T, Rudnick MR.

    Curr Opin Nephrol Hypertens. 2008 Nov;17(6):616-23. Review.PMID: 18941356 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.

    Walker PD, Brokering KL, Theobald JC.

    Pharmacotherapy. 2003 Dec;23(12):1617-26. Review.PMID: 14695041 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.

    Huber W, Eckel F, Hennig M, Rosenbrock H, Wacker A, Saur D, Sennefelder A, Hennico R, Schenk C, Meining A, Schmelz R, Fritsch R, Weiss W, Hamar P, Heemann U, Schmid RM.

    Radiology. 2006 Jun;239(3):793-804.PMID: 16714461 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

    Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR.

    Am J Kidney Dis. 2009 Apr;53(4):617-27. Epub 2008 Nov 22. Review.PMID: 19027212 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).

    Ng TM, Shurmur SW, Silver M, Nissen LR, O'Leary EL, Rigmaiden RS, Cieciorka M, Porter LL, Ineck BA, Kline ME, Puumala SE.

    Int J Cardiol. 2006 May 24;109(3):322-8. Epub 2005 Jul 22.PMID: 16039733 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevention of radiocontrast nephropathy.

    Lin J, Bonventre JV.

    Curr Opin Nephrol Hypertens. 2005 Mar;14(2):105-10. Review.PMID: 15687835 [PubMed - indexed for MEDLINE]Related articles

    12.

    Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?

    Heng AE, Cellarier E, Aublet-Cuvelier B, Decalf V, Motreff P, Marcaggi X, Deteix P, Souweine B.

    Clin Nephrol. 2008 Dec;70(6):475-84.PMID: 19049703 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prophylaxis strategies for contrast-induced nephropathy.

    Pannu N, Wiebe N, Tonelli M; Alberta Kidney Disease Network.

    JAMA. 2006 Jun 21;295(23):2765-79. Review.PMID: 16788132 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prevention of contrast-induced nephropathy in vascular surgery patients.

    Lawlor DK, Moist L, DeRose G, Harris KA, Lovell MB, Kribs SW, Elliot J, Forbes TL.

    Ann Vasc Surg. 2007 Sep;21(5):593-7.PMID: 17823041 [PubMed - indexed for MEDLINE]Related articles

    15.

    Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.

    Pannu N, Tonelli M.

    Curr Opin Nephrol Hypertens. 2006 May;15(3):285-90. Review.PMID: 16609296 [PubMed - indexed for MEDLINE]Related articles

    16.

    Contrast-induced nephropathy: a review.

    Sanaei-Ardekani M, Movahed MR, Movafagh S, Ghahramani N.

    Cardiovasc Revasc Med. 2005 Apr-Jun;6(2):82-8. Review.PMID: 16263365 [PubMed - indexed for MEDLINE]Related articles

    17.

    Preventing contrast-induced nephropathy with fenoldopam.

    Hunter DW, Chamsuddin A, Bjarnason H, Kowalik K.

    Tech Vasc Interv Radiol. 2001 Mar;4(1):53-6.PMID: 11981789 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.

    Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK.

    Catheter Cardiovasc Interv. 2002 Nov;57(3):279-83.PMID: 12410497 [PubMed - indexed for MEDLINE]Related articles

    19.

    Current trials of interventions to prevent radiocontrast-induced nephropathy.

    Asif A, Garces G, Preston RA, Roth D.

    Am J Ther. 2005 Mar-Apr;12(2):127-32. Review.PMID: 15767830 [PubMed - indexed for MEDLINE]Related articles

    20.

    Contrast-induced nephropathy: epidemiology and prevention.

    Bagshaw SM, Culleton BF.

    Minerva Cardioangiol. 2006 Feb;54(1):109-29. Review.PMID: 16467746 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity